508 related articles for article (PubMed ID: 24376083)
1. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Jeppesen DK; Nawrocki A; Jensen SG; Thorsen K; Whitehead B; Howard KA; Dyrskjøt L; Ørntoft TF; Larsen MR; Ostenfeld MS
Proteomics; 2014 Mar; 14(6):699-712. PubMed ID: 24376083
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
[TBL] [Abstract][Full Text] [Related]
3. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method.
Yang G; Lu W; Yu D; Sun C; Guo J; Li Z; Guan F
Molecules; 2016 Jan; 21(1):84. PubMed ID: 26784156
[TBL] [Abstract][Full Text] [Related]
5. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
Yoshida K; Tsuda M; Matsumoto R; Semba S; Wang L; Sugino H; Tanino M; Kondo T; Tanabe K; Tanaka S
Cancer Sci; 2019 Jul; 110(7):2119-2132. PubMed ID: 31141251
[TBL] [Abstract][Full Text] [Related]
6. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Ji H; Greening DW; Barnes TW; Lim JW; Tauro BJ; Rai A; Xu R; Adda C; Mathivanan S; Zhao W; Xue Y; Xu T; Zhu HJ; Simpson RJ
Proteomics; 2013 May; 13(10-11):1672-86. PubMed ID: 23585443
[TBL] [Abstract][Full Text] [Related]
7. Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state.
Garnier D; Magnus N; Meehan B; Kislinger T; Rak J
Exp Cell Res; 2013 Oct; 319(17):2747-57. PubMed ID: 23954818
[TBL] [Abstract][Full Text] [Related]
8. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Lazar I; Clement E; Ducoux-Petit M; Denat L; Soldan V; Dauvillier S; Balor S; Burlet-Schiltz O; Larue L; Muller C; Nieto L
Pigment Cell Melanoma Res; 2015 Jul; 28(4):464-75. PubMed ID: 25950383
[TBL] [Abstract][Full Text] [Related]
9. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
[TBL] [Abstract][Full Text] [Related]
10. Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
Huang CS; Ho JY; Chiang JH; Yu CP; Yu DS
Cells; 2020 Jun; 9(6):. PubMed ID: 32517366
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Profiling of Exosomes Secreted by Breast Cancer Cells with Varying Metastatic Potential.
Gangoda L; Liem M; Ang CS; Keerthikumar S; Adda CG; Parker BS; Mathivanan S
Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 29115712
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X
Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829
[TBL] [Abstract][Full Text] [Related]
13. Profiling the evolution of human metastatic bladder cancer.
Nicholson BE; Frierson HF; Conaway MR; Seraj JM; Harding MA; Hampton GM; Theodorescu D
Cancer Res; 2004 Nov; 64(21):7813-21. PubMed ID: 15520187
[TBL] [Abstract][Full Text] [Related]
14. In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Sinha A; Ignatchenko V; Ignatchenko A; Mejia-Guerrero S; Kislinger T
Biochem Biophys Res Commun; 2014 Mar; 445(4):694-701. PubMed ID: 24434149
[TBL] [Abstract][Full Text] [Related]
15. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
16. Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression.
Greening DW; Gopal SK; Mathias RA; Liu L; Sheng J; Zhu HJ; Simpson RJ
Semin Cell Dev Biol; 2015 Apr; 40():60-71. PubMed ID: 25721809
[TBL] [Abstract][Full Text] [Related]
17. Proteomics analysis of bladder cancer exosomes.
Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the roles of exosomes in colorectal cancer liver metastasis.
Wang X; Ding X; Nan L; Wang Y; Wang J; Yan Z; Zhang W; Sun J; Zhu W; Ni B; Dong S; Yu L
Oncol Rep; 2015 May; 33(5):2445-53. PubMed ID: 25760247
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro.
Yang L; Wu XH; Wang D; Luo CL; Chen LX
Mol Med Rep; 2013 Oct; 8(4):1272-8. PubMed ID: 23969721
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Proteomics Analysis Reveals a Secretory Path- and Status-Dependent Signature of Exosomes Released from Tumor-Associated Macrophages.
Zhu Y; Chen X; Pan Q; Wang Y; Su S; Jiang C; Li Y; Xu N; Wu L; Lou X; Liu S
J Proteome Res; 2015 Oct; 14(10):4319-31. PubMed ID: 26312558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
